P. Ffrench

发表

A splicing donor site point mutation in intron 6 of the plasmin inhibitor (α2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency

P. de Mazancourt, M. Dechavanne, M. Hanss, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects

J. Boissel, M. Dechavanne, P. Nony, 1996 .

LETTERS TO THE EDITOR: Four cases of hypofibrinogenemia associated with four novel mutations

M. Bertrand, C. Vinciguerra, M. Hanss, 2005, Journal of thrombosis and haemostasis : JTH.

CDK2 is involved in the S-phase lengthening induced by glucocorticoids in normal human lymphocytes.

J. Magaud, M. Ffrench, P. Ffrench, 2003, European journal of cell biology.

Early Fibrinogen Degradation Coagulopathy Is Predictive of Parenchymal Hematomas in Cerebral rt-PA Thrombolysis: A Study of 157 Cases

P. Adeleine, J. Honnorat, P. Trouillas, 2004, Stroke.

Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data.

P. Adeleine, P. Trouillas, N. Nighoghossian, 1996, Stroke.

Plasma cell proliferation in monoclonal gammopathy: relations with other biologic variables--diagnostic and prognostic significance.

M. Ffrench, P. Ffrench, P. Bryon, 1995, The American journal of medicine.

Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke.

N. Nighoghossian, P. de Mazancourt, L. Derex, 2013, Thrombosis research.

Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases

A. Bauters, M. Wolf, P. Ffrench, 2009, Intensive Care Medicine.

Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin versus autologous fresh whole blood transfusion.

P. Ffrench, S. Estanove, O. Jegaden, 1992, Journal of cardiothoracic and vascular anesthesia.

Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.

J. Amiral, M. Dechavanne, O. Bastien, 1993, Journal of Thoracic and Cardiovascular Surgery.

Thromboresistance of bulk heparinized catheters in human.

J. Baguet, D. Cathignol, P. Ffrench, 1987, Thrombosis research.

Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism.

J. Lehot, O. Bastien, C. Bauer, 2008, Anesthesia and analgesia.

Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.

P. Morange, Y. Gruel, E. de Maistre, 2006, Blood.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia.

J. Lehot, O. Bastien, V. Piriou, 2001, The Annals of thoracic surgery.

Population Pharmacokinetics of Recombinant Factor VIIa in Volunteers Anticoagulated with Acenocoumarol

J. Boissel, J. Boissel, M. Dechavanne, 1998, Thrombosis and Haemostasis.

Two novel fibrinogen variants found in patients with pulmonary embolism and their families

P. de Mazancourt, M. Dechavanne, M. Hanss, 2003, Journal of thrombosis and haemostasis : JTH.

The effect of recombinant factor VIIa (NovoSeven™) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0

J. Boissel, M. Dechavanne, P. Nony, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.

F. Berger, B. Coiffier, J. Magaud, 1994, American journal of clinical pathology.

Search for red blood cell cytoskeleton abnormalities in patients with venous thrombosis

M. Hanss, P. Ffrench, S. Chariout, 2004, Journal of thrombosis and haemostasis : JTH.

Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension.

J. Lehot, P. Ffrench, S. Estanove, 1992, Anesthesiology.

Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial.

J. Riou, J. Boissel, J. Orgiazzi, 2000, Maturitas.

Increased thrombosis incidence in a family with an inherited protein S deficiency and a high oxygen affinity hemoglobin variant

C. Négrier, B. Boneu, M. Dechavanne, 1994, American journal of hematology.

Comparative evaluation of plasma thrombospondin beta-thromboglobulin and platelet factor 4 in acute myocardial infarction.

P. Touboul, M. Dechavanne, P. Ffrench, 1985, Thrombosis research.

Significant Reduction in the Binding of a Monoclonal Antibody (LYP 18) Directed Against the IIb/IIIa Glycoprotein Complex to Platelets of Patients Having Undergone Extracorporeal Circulation

M. Dechavanne, M. Ffrench, P. Ffrench, 1987, Thrombosis and Haemostasis.

Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia

Y. Bertrand, M. Ffrench, Y. Mekki, 1999, Leukemia.

Does p16ink4a expression increase with the number of cell doublings in normal and malignant lymphocytes?

C. Galmarini, Y. Bertrand, M. Ffrench, 2007, Leukemia research.

Treatment of inherited protein C deficiency by replacement therapy with the French purified plasma‐derived protein C concentrate (PROTEXEL®)

Y. Gruel, B. Tardy, H. Chambost, 2007, Vox sanguinis.

[Predictive value of D-dimer assay in superficial thrombophlebitis of the lower limbs].

F. Allaert, M. Hanss, P. Ffrench, 2007, Journal des maladies vasculaires.

The natural occurrence of human fibrinogen variants disrupting inter-chain disulfide bonds (AαCys36Gly, AαCys36Arg and AαCys45Tyr) confirms the role of N-terminal Aα disulfide bonds in protein assembly and secretion

P. Morange, P. de Mazancourt, J. Abgrall, 2011, Haematologica.

Priming effect of adrenic acid (22:4(n-6)) on tissue factor activity expressed by thrombin-stimulated endothelial cells.

B. Tardy, M. Dechavanne, P. Ffrench, 1992, Atherosclerosis.

Bcl-2, Cell Cycle Regulatory Proteins and Corticosensitivity in Childhood Acute Lymphoblastic Leukaemia

J. Magaud, Y. Bertrand, M. Ffrench, 2001, Leukemia & lymphoma.

Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation

C. Négrier, M. Dechavanne, M. Hanss, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Thalamic stroke and congenital factor V deficiency.

B. Croisile, G. Aimard, M. Trillet, 1991, Stroke.

Expression of adhesion molecules in endothelial cells during allogeneic bone marrow transplantation

M. Dechavanne, M. Ffrench, P. Ffrench, 1994, European journal of haematology.

Differential expression of cell proliferation regulatory proteins in B‐ and T‐lineage acute lymphoblastic leukaemias

R. Rimokh, Y. Bertrand, M. Ffrench, 1996, British journal of haematology.

Antifibrinolytic Therapy in Cardiac Surgery

J. Lehot, J. Obadia, P. Ffrench, 1997 .

Autolysosomes accumulate during in vitro CD8+ T-lymphocyte aging and may participate in induced death sensitization of senescent cells

J. Magaud, L. Genestier, S. Hayette, 2004, Experimental Gerontology.

Role of BCL‐2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemia

Y. Bertrand, M. Ffrench, P. Ffrench, 2000, British journal of haematology.

[Association of dysfibrinogenemia and thrombosis. Apropos of a family (Fibrinogen Melun) and review of the literature].

P. Ffrench, J. Conard, M. Samama, 1995, Annales de medecine interne.

A new electrophoretic variant of fibrinogen associated with venous thromboembolism, fibrinogen Bordeaux Aα Arg439→Cys

C. Vergnes, P. de Mazancourt, M. Hanss, 2008, Journal of thrombosis and haemostasis : JTH.

Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.

M. Ffrench, P. Ffrench, N. Baghdassarian, 1998, Experimental cell research.

Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.

Wei Li, P. Adeleine, J. Honnorat, 1998, Stroke.

IN VITRO TESTS FOR ASSESSING HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIENTS AFTER ELECTIVE HIP REPLACEMENT

C. Négrier, M. Dechavanne, C. Colin, 2002, International Journal of Technology Assessment in Health Care.

Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects.

J. Boissel, M. Dechavanne, P. Nony, 1996, Canadian journal of physiology and pharmacology.

CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas.

F. Berger, M. Ffrench, P. Ffrench, 1999, Leukemia & lymphoma.

[How can we optimize medical orderings in intensive care unit (ICU)?].

D. Revel, M. Reverdy, J. Lehot, 2010, Annales francaises d'anesthesie et de reanimation.

Fibrinogen and von Willebrand Factor and Susceptibility Vessel Sign on T2*-Weighted Gradient Echo Imaging

N. Nighoghossian, A. Farghali, A. Schott, 2014, European Neurology.

High dose aprotinin or intraoperative autransfusion : Effects on blood loss and blood transfusion after cardiopulmonary bypass

P. Ffrench, S. Estanove, O. Jegaden, 1990 .